SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-20-009608
Filing Date
2020-04-24
Accepted
2020-04-24 06:03:56
Documents
5
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10007589x3_defa14a.htm DEFA14A 17508
2 nc10007589x3_noticecards1.jpg GRAPHIC 497964
3 nc10007589x3_noticecards2.jpg GRAPHIC 678805
4 nc10007589x3_noticecards3.jpg GRAPHIC 329659
5 nc10007589x3_noticecards4.jpg GRAPHIC 113201
  Complete submission text file 0001140361-20-009608.txt   2249976
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-19125 | Film No.: 20812399
SIC: 2834 Pharmaceutical Preparations